FOXO1 and Hyperinsulinemia: This selective impairment in FoxO1 phosphorylation leads to increased expression of gluconeogenic enzymes, glucose intolerance, hyperinsulinemia, further activation of hepatic aPKC and Akt, and further increases in expression of lipogenic enzymes and proinflammatory factors.